Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125254471 | 12525447 | 1 | I | 20160531 | 20160624 | 20160704 | 20160704 | EXP | FR-009507513-1606FRA012956 | MERCK | 49.19 | YR | M | Y | 0.00000 | 20160704 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125254471 | 12525447 | 1 | PS | TEMODAL | TEMOZOLOMIDE | 1 | Oral | 140 MG, QD (75 MG/M2) | 106260 | MG | N | 21029 | 140 | MG | CAPSULE | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125254471 | 12525447 | 1 | Anaplastic oligodendroglioma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125254471 | 12525447 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125254471 | 12525447 | Agranulocytosis | |
125254471 | 12525447 | Anaemia | |
125254471 | 12525447 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125254471 | 12525447 | 1 | 20140504 | 20160531 | 0 |